Latest filing published 02 Apr 2018 for Cardiome Pharma Corp..
William L. Hunter appears in our data through filings on Cardiome Pharma Corp. shares, published by SEDI. In total, 13 filings cover trades dated from 11 June 2007 to 28 March 2018.
Purchases make up the whole of the open-market record (2 purchases, €115k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 8 option exercises.
The newest entry dates from 2 April 2018: an option exercise, in Cardiome Pharma Corp. The clock since the last published purchase (11 August 2016) now reads 3,727 days. Typically, a trade is published a median of 3 days after it takes place. The shorter that gap, the sooner other investors can see what insiders have done. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations